October 31st 2024
The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.
Recent study demonstrates potential of a synbiotic formulation for precision microbiome modulation
August 31st 2023The study was funded by Prolacta Bioscience and featured its synbiotic consisting of Bifidobacterium longum subspecies infantis (B. infantis) and human milk oligosaccharides (HMOs).
Probiotic strain from Probi may support metabolic health according to recent study
August 3rd 2023Results showed that compared to placebo, subjects taking the probiotic strain experienced a greater reduction in remnant cholesterol which is significantly associated with improvements in endothelial function.